HARROW, INC. — Director's Dealing 2017

Apr 18, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2017-04-13

Reporting Person: Edwards Clayton D (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-13	Option - Right to Buy	$3.77	A	55000	Acquired	2027-04-13	Common Stock (55000)	Direct

Footnotes

F1: Represents stock options granted under the Issuer's 2007 Stock Incentive and Awards Plan. The stock options vests over a 4-year period, with 25% of the total number of shares subject to the option vesting on the one-year anniversary of the grant date and the remaining shares subject to the option vesting in equal installments each quarterly period following the one-year anniversary of the grant date.